Lecture Theatre 003
-
International
View our Global FootprintBusiness
Northumbria University is proud to offer a range of Professional, Statutory and Regulatory Body (PSRB) approved & accredited courses and programmes. Explore our list of courses and programmes under our Education and Training page.
More on our Business ServicesResearch
Northumbria is a research-rich, business-focused, professional university with a global reputation for academic quality. We conduct ground-breaking research that is responsive to the science & technology, health & well being, economic and social and arts & cultural needs for the communities
Discover more about our ResearchAlumni
Northumbria University is renowned for the calibre of its business-ready graduates. Our alumni network has over 253,000 graduates based in 178 countries worldwide in a range of sectors, our alumni are making a real impact on the world.
Our AlumniLecture Theatre 003
-
B cells are an essential part of our adaptive immune system and are responsible for the production of antibodies. These Y-shaped molecules can specifically recognize foreign invaders (e.g. SARS-CoV-2) and prevent their entry into the body.
Shortly after infection or vaccination, B cells with the appropriate specificity become activated and can rapidly produce large quantities of antibodies directed against the offending agent. However, over time the levels of specific antibodies in the body can drop below protective levels. Fortunately, some of the B cells become long-lived memory cells and can rapidly be reawakened to produce protective antibodies once more, even against newer versions of virus.
In a fascinating lecture, Professor Greg Kirchenbaum will discuss his current research focusing on the detection of such specific memory B cells in the blood using a technique called ImmunoSpot. He will explain how detection of memory B cells using the ImmunoSpot technique promises to offer insights that measurements of antibody levels in blood cannot.
About the Speaker
Professor Greg Kirchenbaum is Director of B cell Research, Cellular Technology Ltd, Cleveland, Ohio, USA. He received his BSc honours from Florida State University in Biology and went on to the prestigious Immunology Department at the University of Colorado to work on his PhD in the area of B cell tolerance with Lawrence Wysocki. Post-doctoral fellowships at the Vaccine and Gene Therapy Institute of Florida, and Center for Vaccines and Immunology, University of Georgia, followed, where he worked with Ted Ross.
In 2018 Professor Kirchenbaum joined Cellular Technology Ltd (CTL) in Cleveland, Ohio, to work with Professor Paul V. Lehmann MD/PhD, where he is now Director of B cell research. He has been instrumental in developing the B cell ImmunoSpot assay platform at CTL. B cell and antibody responses have been a constant theme in his career, and he has over 40 publications in prestigious journals and given numerous keynote presentations. He has a close collaboration with Professor Stephen Todryk at Northumbria University, where they co-supervise a PhD student.
-
Events
Northumbria University convened parliamentarians, policymakers, employers and sector leaders…
Students from Northumbria University’s Business Clinic are helping a County Durham church to…
Northumbria University is launching The Bridge, a flexible route into higher education for…
A Northumbria University academic curated a major retrospective of one of India's most influential…
Northumbria has been selected as a founding member of the Defence Universities Alliance (DUA),…
Northumbria University researchers are calling on women to support a new study, which could…
Northumbria University is awarding honorary degrees to 14 distinguished individuals at its…
The creative skills of final year Fashion students from Northumbria University have once again…
Northumbria University
-
Northumbria University
-